Expertise in
5
conditions

Dr. Stergios Zacharoulis

Pediatric Hematology Oncology
16 Hamlet Square, 
London, GB 
Expertise in
5
conditions
16 Hamlet Square, 
London, GB 
OverviewLocationsClinical Research

Overview

Stergios Zacharoulis is a Pediatric Hematologist Oncology provider in London, United Kingdom. Dr. Zacharoulis is highly rated in 5 conditions, according to our data. His top areas of expertise are Diffuse Midline Glioma H3 K27M-Mutant, Pineocytoma, Glioma, and Brain Stem Cancer.

His clinical research consists of co-authoring 46 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in NY
Languages Spoken
English
Gender
Male

Locations

16 Hamlet Square, London, NW21SR, United Kingdom

Additional Areas of Focus

Dr. Zacharoulis has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Feasibility Study Examining the Use of Non-Invasive Focused Ultrasound (FUS) With Oral Panobinostat Administration in Children With Progressive Diffuse Midline Glioma (DMG)
A Feasibility Study Examining the Use of Non-Invasive Focused Ultrasound (FUS) With Oral Panobinostat Administration in Children With Progressive Diffuse Midline Glioma (DMG)
Enrollment Status: Terminated
Publish Date: June 08, 2025
Intervention Type: Device, Drug
Study Drug: Panobinostat
Study Phase: Phase 1
A Phase I Study Examining the Feasibility of Intermittent Convection-Enhanced Delivery (CED) of MTX110 for the Treatment of Children With Newly Diagnosed Diffuse Midline Gliomas
A Phase I Study Examining the Feasibility of Intermittent Convection-Enhanced Delivery (CED) of MTX110 for the Treatment of Children With Newly Diagnosed Diffuse Midline Gliomas
Enrollment Status: Completed
Publish Date: December 18, 2023
Intervention Type: Drug, Device
Study Drug: Infusate with MTX110 and gadolinium
Study Phase: Phase 1
View 1 Less Clinical Trial

46 Total Publications

Blood-brain barrier opening with neuronavigation-guided focused ultrasound in pediatric patients with diffuse midline glioma.
Blood-brain barrier opening with neuronavigation-guided focused ultrasound in pediatric patients with diffuse midline glioma.
Journal: Science translational medicine
Published: November 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Zacharoulis's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile